Anzeige
Mehr »
Login
Montag, 03.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
Warum diese Aktie sich im heutigen Goldmarkt abhebt…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D6F4 | ISIN: KYG6256B1068 | Ticker-Symbol: 193
NASDAQ
30.01.25
15:30 Uhr
11,960 US-Dollar
0,000
0,00 %
1-Jahres-Chart
DENALI CAPITAL ACQUISITION CORP Chart 1 Jahr
5-Tage-Chart
DENALI CAPITAL ACQUISITION CORP 5-Tage-Chart

Aktuelle News zur DENALI CAPITAL ACQUISITION Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.01.Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination36NEW YORK, NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust...
► Artikel lesen
08.01.Denali Capital Acquisition Corp. - 8-K, Current Report-
30.12.24Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from November ...32
11.12.24Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination47NEW YORK, NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust...
► Artikel lesen
11.12.24Denali Capital secures extension for business combination1
11.12.24Denali Capital Acquisition Corp. - 8-K, Current Report-
19.11.24Denali Capital Acquisition Corp. - 10-Q, Quarterly Report-
11.11.24Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination64NEW YORK, NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust...
► Artikel lesen
DENALI CAPITAL ACQUISITION Aktie jetzt für 0€ handeln
06.11.24Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Announces Today the Filing of a Registration Statement on Form S-4 by Denali Capital Acquisition Corp. with the Securities and Exchange Commission Relating to ...3
06.11.24Denali Capital Acquisition Corp. - S-4, Registration of securities, business combinations-
06.11.24Semnur Pharmaceuticals, Inc. - S-4, Registration of securities, business combinations-
28.10.24Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary5
16.10.24Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination ...2
11.10.24Denali Capital Acquisition Corp. - 8-K, Current Report1
11.10.24Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination200NEW YORK, NEW YORK, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that it has deposited into the Company's trust account (the "Trust...
► Artikel lesen
11.09.24Denali Capital secures extension for business combination1
11.09.24Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination68NEW YORK, NEW YORK, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) (the "Company") announced today that it has deposited into the Company's trust account (the...
► Artikel lesen
05.09.24Denali Capital Acquisition Corp. - 8-K, Current Report-
03.09.24Scilex's Semnur Pharmaceuticals to go public through $2.5B SPAC merger as it advances sciatica prospect2
03.09.24Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value128Semnur Pharmaceuticals, Inc. ("Semnur"), a wholly owned subsidiary of Scilex Holding Company (Nasdaq: SCLX, "Scilex"), and Denali Capital Acquisition Corp. (Nasdaq: DECA, the "SPAC") announce the...
► Artikel lesen
Seite:  Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1